Ibogaine, a powerful psychedelic, is gaining attention due to interest from the Trump administration as a potential treatment for addiction and mental health disorders. Once controversial, it is now being explored for medical use, with discussions around safety, regulation, and FDA approval intensifying, sparking widespread debate among scientists, policymakers, and the public.